4//SEC Filing
Marban Linda 4
Accession 0001415889-23-008130
CIK 0001133869other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:00 PM ET
Size
7.9 KB
Accession
0001415889-23-008130
Insider Transaction Report
Form 4
Marban Linda
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-05-12−41,497→ 0 totalExercise: $1.39Exp: 2023-05-14→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2023-05-12$1.39/sh+20,749$28,841→ 198,604 total
Footnotes (3)
- [F1]Half of the shares of Common Stock acquired upon exercise of this option were delivered to the Reporting Person's ex-spouse pursuant to a domestic relations order, which transaction is exempt from Section 16 pursuant to Rule 16a-12 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Person no longer reports as beneficially owned any securities owned by her ex-spouse.
- [F2]This figure reflects the acquisition of 132,060 shares of Common Stock from the Reporting Person's ex-spouse pursuant to a domestic relations order, which acquisition is exempt from Section 16 pursuant to Rule 16a-12 under the Exchange Act. The Reporting Person no longer reports as beneficially owned any securities owned by her ex-spouse.
- [F3]The stock option award is fully vested and exercisable.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001593084
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:00 PM ET
- Size
- 7.9 KB